← All trials
NCT00043745
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2003
- Primary completion
- Apr 30, 2008
- Completion date
- —
- First posted
- Aug 14, 2002
- Last posted
- Feb 7, 2013
- Enrollment
- 224
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Iowa State UniversityLead sponsor
- Iowa State UniversityOverall official - principal investigator
- Iowa State UniversityReponsible party - principal investigator
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.